Trial Profile

Phase 1 trial of MBP091 for treatment of Marburg virus infections

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 17 Jun 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MBP 091 (Primary)
Indications Marburg virus disease
Focus Adverse reactions
Sponsors Mapp Biopharmaceutical

Most Recent Events

17 Jun 2019 New trial record
11 Jun 2019 According to an Mapp Biopharmaceutical Media release, the company has been awarded an advanced research and development contract by the Biomedical Advanced Research and Development Authority(BARDA) to advance MBP091 though the completion of a Phase 1 clinical trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com